Z.leaf Expander
Z.leaf Expander
Z.leaf Expander
Cossellu Gianguido2
Farronato Marco3
Silvestrini-Biavati Armando4
Lanteri Valentina5
1
DDS, PhD. Assistant Professor. Department of Orthodontics, University of Genova, Genoa, Italy
2
DDS, PhD. Research Fellow. Department of Biomedical Surgical and Dental Sciences, University
of Milan, Milan, Italy
3
DDS, PhD. Research Fellow. Department of Biomedical Surgical and Dental Sciences, University
of Milan, Milan, Italy
4
MD, DDS. Professor. Department of Orthodontics, University of Genova, Genoa, Italy
5
DDS, PhD. Research Fellow. Department of Biomedical Surgical and Dental Sciences, University
of Milan, Milan, Italy
Author contributions: A.U. contributed to the design of the study, analysis and interpretation of data and drafted the
manuscript; C.G. contributed to acquisition and interpretation of data and critically revised the manuscript; F.M.
contributed to interpretation of data; V.L. contributed to acquisition and interpretation of data; S.B.A. contributed to
conception and design of the study and critically revised the manuscript.
This article has been accepted for publication and undergone full peer review but has not been
through the copyediting, typesetting, pagination and proofreading process, which may lead to
differences between this version and the Version of Record. Please cite this article as doi:
10.1111/IPD.12612
This article is protected by copyright. All rights reserved
Accepted Article
Conflict of interest: Ugolini Alessandro, Cossellu Gianguido, Farronato Marco, Silvestrini-Biavati Armando,
Lanteri Valentina declare that have no conflict of interest.
Corresponding Author:
Alessandro Ugolini
[email protected]
Accepted Article
Abstract
BACKGROUND: Pain suffered by the young patient is the most frequent symptom during
orthodontic treatment and is the one that most frightens children and causes worry in their
families.
AIM: to investigate pain perception and function impairment during the first week of activation
of two palatal expansion screws.
DESIGN: 101 subjects were randomly divided into two groups: RME group included patients
treated with the standard hyrax expansion screw and LEAF group included patients treated with
Leaf Expander appliance. Pain intensity was assessed via the Wong-Baker scale. A questionnaire
on oral function impairments was also compiled by the patients.
RESULTS: The pain Scale analysis showed that patients in the RME group suffered from a
significantly higher level of pain than those in the LEAF group (88.6% vs 25%, p<0.01). RME
group showed highest pain indexes from day 1 to day 4 (51,4% RME vs 9,7% LEAF suffered at
least once from strong pain in the first four days, p<0.01). Furthermore, oral functions were
similarly affected in both groups.
KEYWORDS
maxillary expansion, pain, palatal expansion, leaf expander
Introduction
Maxillary arch expansion through a fixed appliance is a well-known and consolidated practice in
clinical orthodontics but current findings of “evidence-based dentistry” have not yet identified an
ideal clinical expansion protocol. Recent systematic reviews1,2 have shown that both rapid and
slow expansion protocols are clinically effective on the primary outcome (i.e. the resolution of
the crossbite with a significant increase of skeletal transversal dimension in the maxillary
transverse deficiency subjects). So, the choice of appliance type solely based on its ability to
solve maxillary constriction issues is no longer the main selection criteria and the relevant choice
of the orthodontist should, therefore, be based on timing3,4 and on a "patient-oriented" device,
that can minimize the various possible side effects, such as appliance breakages, functional
impairments, injuries to the periodontal tissues and, of course, pain.5-12
In orthodontic daily practice, pain suffered by the young patient is the most frequent symptom
during treatment and is the one that most frightens children and causes worry in their families.13
Available literature shows that rapid maxillary arch expansion is, among the early orthodontic
therapies, the one with the highest incidences of pain (up to 98%) as an adverse symptom
reported by patients.5-9 Pain could be related to the rapid expansion protocol, during which, for
each activation of the screw (0.2 or 0.25 mm) the force expressed can reach up to 10 pounds. 14-18
thus the present study aims at investigating and analyzing the perception of pain and function
impairment during the first week of activation with two palatal expansion screws to identify the
effect of different maxillary arch expansion protocol on the pain perception and discomfort in
young patients.
The present multicentric randomized study was conducted at the Departments of Orthodontics of
the Universities of Milan and Genoa (Italy). The trial was first approved by the Institutional
Ethical Review Board (Fondazione IRCSS Ca’ Granda n° 936-1666/13) and published on
ClinicalTrials.gov (ClinicalTrials.gov Identifier: NCT03757468,
https://clinicaltrials.gov/ct2/show/NCT03757468). CONSORT documents, including a checklist
and a flow-chart have been used to report the findings.
One-hundred and sixteen consecutive subjects with transversal maxillary deficiency (intermolar
width <30 mm, with or without crossbite) were randomly assigned to RME group (treated with
the standard hyrax expansion screw) or LEAF Group (treated with Leaf Expander appliance).
The treating clinician was blinded from the randomization procedure, but because of clear
differences in appliance design, blinding was not possible during the treatment period itself. The
data examiner was also blinded from the treatment protocol. Both appliances were anchored on
the second deciduous molars. All subjects had a Class I or Class II dental malocclusion with uni-
or bilateral crossbite and/or constricted maxilla and were selected before the puberal peak
(cervical vertebral maturation stage 1–3).
Patients with previous orthodontic treatment, hypodontia in any quadrant excluding third molars,
inadequate oral hygiene, craniofacial syndromes, or cleft lip or palate were considered ineligible
for the study and thus duly excluded from it.
Statistical Analysis
Shapiro-Wilk’s test showed that pain intensity data were normally distributed, parametric
statistics were thus applied. Descriptive statistics, median value, standard deviation and
confidence interval (95% CI) were calculated. Differences between groups in pain intensity were
tested with parametric T student test and Risk Ratio (RR) analysis was performed to assess the
questionnaire data. Probabilities of less than 0.05 were accepted as significant in all statistical
analyses.
The sample size was calculated 'a priori' to obtain a statistical power of the study greater than
0.85 at an alpha of 0.05, using the mean values and standard deviations of pain intensity during
maxillary arch expansion therapy found by Baldini and co-authors (“overall pain”: mean
0.80±1.22 and 1.88 ±2.15)9 and resulted in a minimum of 47 subjects for each group. Moreover,
a drop out of 20% was considered and the final sample size comprised a minimum of 58 subjects
for each group. The effect size (ES) coefficient (d)25 was also calculated. An ES of .2 to .3 might
be a ‘‘small’’ effect and thus a small clinically significant difference, about .5 a ‘‘medium’’
effect, and 0.8 to infinity a ‘‘large’’ effect.
Results
Three patients in the LEAF group and two patients in the RME group did not complete the
questionnaire, eight subjects, all in the RME group, did not follow the prescribed activation
protocol at home. Two subjects in the LEAF group missed the appointment and did not receive
the allocation. Fifteen subjects were thus excluded from the study and the final sample
comprised 101 subjects. Crossbites and traversal maxillary discrepancy were entirely corrected
in 100% of the subjects at the end of the expansion active phase.
The Wong-Baker Faces Pain Scale analysis showed that patients in the RME group suffered
from a significant generalised sensation of pain during the first week of screw activation
Discussion
From a clinical point of view correction of crossbites and traversal maxillary discrepancy were
achieved in all patients with both appliances. The jackscrew and the shape memory leaf spring
expander have different methods of activation: the jackscrew or expansion screw (eg. hyrax) is a
telescoping appliance that requires several patient activations to achieve the maxillary arch
expansion. The memory leaf springs instead, due to their superelastic nature, required only a few
activations or no activation at all because of its reliance upon elastic restoration forces to achieve
the desired expansion. In the jackscrew, to a given amount of screw turn corresponds a
determined amount of expansion (from 0.20 to 0.25 mm), so this allows clinicians to calculate
the number of activations required to achieve the desired expansion. But it also suffers from
Conclusion
Pain suffered during maxillary arch expansion is influenced by the choice of screw and
activation protocol and the use of continuous force through the nickel-titanium spring allows
avoiding the worst levels of pain in the first days of activation. Leaf expander proved itself an
effective and efficient expansion appliance in the prevention of pain.
Pain is the most frequent symptom during maxillary arch expansion treatment and is the
one that most frightens children and causes worry in their families.
More than 50% of patients treated with the rapid maxillary expander reported strong pain
at least once in the first four days of treatment while in the Leaf Expander group less than
10% of the subjects suffered at least once from a level of pain indicated as strong and the
first two days only.
REFERENCES
Excluded (n=0)
Other reasons (n=0 )
Randomized (n=114)
Allocation
Allocated to intervention (LEAF) (n=58) Allocated to intervention (RME) (n=58)
Received allocated intervention (n=56) Received allocated intervention (n=58)
Did not receive allocated intervention (n=2, Did not receive allocated intervention (give
missed appointment) reasons) (n=0 )
Follow-Up
Lost to follow-up Lost to follow-up
Not complete the questionnaire (n=3) Not complete the questionnaire (n=2)
Not follow the prescribed activation protocol) (n=8)
Analysis
Analysed (n=53) Analysed (n=48)
Excluded from analysis (give reasons) (n=0) Excluded from analysis (give reasons) (n=0)
Table 2. Self-Reported Questions Concerning Pain and Discomfort, Analgesic Consumption in the first
Accepted Article
week of treatment (modified from Feldman and Bazagani23)
1 - Pain intensity
- Do you now have pain? And for how many days?
- Do you have pain from the molars?
- Do you have pain from the incisors?
- Do you have pain from the upper jaw?
- Do you have pain from the palate?
- Do you have pain from head?
- Do you have pain during appliance activation?
2 - Analgesic consumption
Have you used analgesics for pain from your jaws, teeth, or face?
If yes, what kind of analgesic and dosage did you use?
3 - Jaw function impairment
If you have pain or discomfort in your teeth and jaws, how
much does that affect
- Speaking
- Salivation (hypersalivation)
- Swallowing
Table 3. Discomfort and analgesic consumption in the first week of therapy; * P = .05; ** P = .01.,
Accepted Article
*** P =.001
RME (%) LEAF (%) Relative Risk Ratio 95% CI Significance level
Difficulty in Swallowing 79.2 84.9 0.93 0.77 - 1.12 0.74
Hyersalivation 81.3 79.2 1.02 0.84 - 1.24 0.8
Difficulty in Speaking 87.5 92.5 0.94 0.82 - 1.07 0.41
Pain - Posterior teeth 62.5 24.5 2.54 1.51 - 4.28 <0.001***
Pain - Incisors 25.0 5.7 3.31 1.14 - 9.58 0.02*
Pain - Palatal vault 12.5 3.8 3.12 0.70 - 15.63 0.13
Pain - Head 8.3 0.0 4.43 0.51 - 38.15 0.17
Analgesic consumption 25.2 0.0 11.14 1.62 - 90.60 0.01**
Table 4. Pain intensity reported on the Wong-Baker Faces Pain Scale; Student’s t-test for independent samples. M=
Accepted Article
morning questionnaire registration E= evening questionnaire registration. Cohen Effect size: S indicates small clinical
significance; M, medium clinical significance, L, large clinical significance. * P = .05; ** P = .01., *** P =.001
Day 1 M Day 1 E Day 2 M Day 2 E Day 3 M Day 3 E Day 4 M Day 4 E Day 5 M Day 5 Day 6 M Day 6 E Day 7 M Day 7 E
RME
Mean 1.9 2.1 2.7 2.9 2.4 2.2 1.6 1.5 0.9 1.0 0.9 0.7 0.7 0,9
group
SD 1.0 1.1 1.2 1.1 1.0 1.0 1.0 1.1 1.2 0.9 0.9 0.8 0.5 0,6
CI 0.2 1.8 2.3 2.6 2.1 1.9 1.3 1.1 0.6 0.7 0.6 0.5 0.5 0,8
95% 0.3 2.4 3.1 3.2 2.7 2.5 1.8 1.8 1.3 1.3 1.1 0.9 0.9 1,1
LEAF
Mean 0.8 1.3 1.2 1.2 0.8 0.8 0.7 0.7 0.6 0.7 0.6 0.6 0.6 0,7
group
SD 0.9 0.8 0.8 0.7 0.6 0.6 0.5 0.6 0.9 0.8 0.7 0.9 0.6 0,5
IC 0.6 1.1 1.0 1.0 0.6 0.6 0.7 0.5 0.4 0.5 0.4 0.3 0.4 0,2
95% 1.1 1.5 1.4 1.4 0.9 0.9 0.5 0.8 0.9 0.9 0.8 0.9 0.8 0,7
Test T
RME vs LEAF 0,001*** 0.020** 0.000*** 0.000*** 0.000*** 0.000*** 0.000*** 0.000*** 0.15 0.08 0.07 0.55 0.36 0.08
Cohen Effect Size 1,7 L 0.8 L 1.4 L 1.8 L 1.9 L 1.7 L 1.1 L 0.9 L - - - - - -
Figures Legend
ipd_12612_f1a.tif